Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shibamoto

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 1, 1994
Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation dosesN Oya, Y Shibamoto, T Shibata, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1994
Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II studyB Jeremic, D Grujicic, V Antunovic, et al.
Journal of Neuro-Oncology|January 1, 1994
Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approachB Jeremic, D Grujicic, V Antunovic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1994
The role of cerebrospinal fluid cytology in radiotherapy planning for intracranial germinomaY Shibamoto, Y Oda, J Yamashita, et al.
International Journal of Radiation Biology|May 1, 1990
Pharmacokinetics of 2-nitroimidazole hypoxic cell radiosensitizers in rodent peripheral nervous tissueK Sasai, Y Shibamoto, M Takahashi, et al.
Japanese Journal of Clinical Oncology|February 1, 1997
Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant gliomaY Shibamoto, Y Nishimura, K Tsutsui, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2020
Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodulesN Tomita, K Okuda, S Osaga, et al.
Neurology|November 10, 2010
Postpuncture CSF leakage: a potential pitfall of radionuclide cisternographyK Sakurai, M Nishio, S Sasaki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II studyB Jeremic, Y Shibamoto, L Acimovic, et al.
International Journal of Radiation Biology|January 1, 1991
Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical useY Shibamoto, K Sasai, M Sakaguchi, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|December 1, 1994
Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation dosesN Oya, Y Shibamoto, T Shibata, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1994
Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II studyB Jeremic, D Grujicic, V Antunovic, et al.
Journal of Neuro-Oncology|January 1, 1994
Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approachB Jeremic, D Grujicic, V Antunovic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 1994
The role of cerebrospinal fluid cytology in radiotherapy planning for intracranial germinomaY Shibamoto, Y Oda, J Yamashita, et al.
International Journal of Radiation Biology|May 1, 1990
Pharmacokinetics of 2-nitroimidazole hypoxic cell radiosensitizers in rodent peripheral nervous tissueK Sasai, Y Shibamoto, M Takahashi, et al.
Japanese Journal of Clinical Oncology|February 1, 1997
Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant gliomaY Shibamoto, Y Nishimura, K Tsutsui, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 25, 2020
Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodulesN Tomita, K Okuda, S Osaga, et al.
Neurology|November 10, 2010
Postpuncture CSF leakage: a potential pitfall of radionuclide cisternographyK Sakurai, M Nishio, S Sasaki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II studyB Jeremic, Y Shibamoto, L Acimovic, et al.
International Journal of Radiation Biology|January 1, 1991
Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical useY Shibamoto, K Sasai, M Sakaguchi, et al.
Pageof 20